Good-Faith Exams Explained: Why Every Aesthetic & Rx Patient Needs One

A good-faith exam (GFE) is one of the most misunderstood requirements in the medical aesthetics and wellness industry. Some operators treat it as a formality — a checkbox before the real visit starts. Others skip it entirely, relying on intake forms and assumption. Both approaches create real legal exposure. This guide explains what a good-faith exam actually is, what it must contain, who can perform it, how telehealth fits in, and what happens when facilities get it wrong.

What is a good-faith exam?

A good-faith exam is a medical evaluation conducted by a licensed healthcare practitioner before a prescription is written or a prescription-required treatment is administered. The purpose is to establish a legitimate patient-physician (or patient-practitioner) relationship, document the clinical rationale for treatment, identify contraindications, and create the medical record that underlies all subsequent care.

The term "good faith" comes directly from the legal standard: a prescriber or treating practitioner must act in good faith — meaning with genuine clinical intent and appropriate evaluation — when authorizing medical treatment. This is distinct from a wellness questionnaire, a health history form, or a sales consultation. A GFE is a medical act performed by a licensed clinician.

In medical aesthetics, the GFE requirement applies to any treatment involving prescription medications or devices. That includes:

• Botulinum toxin injections (Botox, Dysport, Xeomin, Daxxify)
• Prescription dermal fillers
• Prescription topicals (tretinoin, hydroquinone, compounded formulas)
• Weight-loss medications (GLP-1 agonists, phentermine, topiramate)
• Hormone therapy, including testosterone replacement (for TRT-specific requirements, see our gym hormone therapy compliance guide)
• IV infusions containing prescription components
• Any compounded medication dispensed to a named patient

Why the GFE exists: the legal foundations

The good-faith exam requirement derives from several overlapping legal frameworks, not a single rule:

State medical practice acts

Every state medical practice act requires that prescription medications be issued only within the context of a legitimate physician-patient relationship. Most state laws define that relationship as requiring, at minimum, an adequate medical history and an appropriate physical examination before treatment. The specifics — what "adequate" means, whether telehealth satisfies the requirement, and what documentation is required — vary by state, but the core principle is consistent: a prescription without a genuine clinical evaluation is an unlawful prescription.

Federal controlled substance law

For Schedule II through V controlled substances, the federal Controlled Substances Act and DEA regulations add a separate layer: a prescription for a controlled substance is valid only if issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. That standard requires an actual examination — not a self-reported symptom list — sufficient to establish a clinical indication. Violations can result in DEA enforcement against the prescribing practitioner's registration and federal criminal exposure in egregious cases.

Telehealth and the Ryan Haight Act

The Ryan Haight Online Pharmacy Consumer Protection Act created the federal requirement that a prescriber must conduct at least one in-person evaluation before prescribing a controlled substance via telehealth — subject to DEA-issued exceptions. Post-COVID telemedicine flexibilities modified some of these requirements, but those flexibilities are subject to change as DEA finalizes its telehealth rules. For non-controlled-substance aesthetic medications, most states permit synchronous telehealth GFEs. For controlled substances, the rules are more complex and highly state-dependent.

What must a good-faith exam actually include?

This is where many med spas fall short. A compliant GFE is not a five-minute video call or a digitally signed intake form. A defensible medical record from a GFE should document:

• Patient identification. Full name, date of birth, and contact information.
• Date and modality of examination. In-person or telehealth (video), with the time zone noted for telehealth visits.
• Chief complaint or treatment request. What the patient is presenting for.
• Relevant medical history. Prior treatments, relevant diagnoses, surgeries, and medications that bear on treatment safety.
• Allergy and adverse reaction history. Including prior reactions to injectables, topical anesthetics, and latex.
• Contraindication review. Active infection at the treatment site, pregnancy/lactation status, autoimmune conditions, anticoagulant use, and any condition that affects treatment appropriateness.
• Relevant physical findings. For injectables: facial anatomy observations, skin quality, prior treatment areas. For Rx medications: weight, blood pressure if clinically relevant, visual assessment of the condition being treated.
• Assessment and plan. The practitioner's clinical judgment that treatment is appropriate, the intended treatment, and any modifications or precautions.
• Practitioner signature, credentials, and date. The record must be attributable to a specific licensed clinician.

"A good-faith exam is not a consent form and it is not a health history intake. It is a medical record created by a licensed clinician who has actually evaluated the patient. The distinction matters when a complaint is filed."

Who can perform a GFE? Scope of practice rules

The practitioner conducting the GFE must be:

• Licensed in the state where the patient is located (for telehealth) or where the treatment is being administered (in-person).
• Operating within their scope of practice for the treatment being authorized. A registered nurse cannot independently conduct a GFE and write a prescription; a nurse practitioner or physician assistant may be able to, depending on state law and their collaborative or supervisory agreement.
• Genuinely independent in their clinical judgment — not directed by non-physician staff or business owners on what treatments to approve.

Estheticians, medical assistants, and non-licensed aesthetics professionals cannot perform a GFE, regardless of their experience or the volume of treatments they have administered. Delegating the GFE function to unlicensed staff — even informally — is one of the most common sources of medical board complaints against med spas and the supervising practitioners associated with them.

Telehealth GFEs: what works and what doesn't

Synchronous telehealth — a live, two-way video visit between the patient and a licensed practitioner — is accepted in most states as a valid means of conducting a GFE for non-controlled-substance aesthetic treatments. The key requirements are:

• The visit must be synchronous (live video). Asynchronous review of photos or a text questionnaire is generally not sufficient to constitute an exam.
• The practitioner must be able to visually assess the patient and the relevant anatomy. For facial injectables, this means seeing the face clearly on camera; for skin conditions, adequate lighting and camera resolution matter.
• The practitioner must be licensed in the state where the patient is physically located during the visit — not just in the state where the facility is located.
• The visit must be documented in a medical record with the same elements described above.

For controlled substances — including testosterone, semaglutide (GLP-1 agonists vary; some are controlled, some are not), and weight-loss controlled medications — check your specific state's telehealth rules. Some states permit fully remote evaluation; others require at least one in-person visit. This is an area of active regulatory development and should be verified with healthcare legal counsel before you structure a telehealth-first program.

GFE frequency: initial exam vs. follow-up visits

A common operational question: does every treatment appointment require a new GFE? The answer depends on the treatment type and how much time has passed since the last evaluation.

For aesthetic injectables at an established practice, many state frameworks permit a treating practitioner to see the patient for a follow-up treatment without a full new GFE — provided the initial GFE was documented, the treatment plan is unchanged, no significant time has elapsed, and the patient has not reported any new medical changes. Most compliance-oriented med spas require a new GFE or at least a clinical check-in at defined intervals (commonly 12 months, or sooner if a patient's medical history changes).

For ongoing prescription medications — hormone therapy, weight management Rx, prescription skincare — follow-up evaluations at clinically appropriate intervals are a medical standard of care requirement, not just a regulatory formality. A patient on testosterone should have labs reviewed and a clinical reassessment at least every six to twelve months. A patient on a GLP-1 agonist should be monitored for side effects and therapeutic response. The GFE for these patients is not a one-time event.

How MDside structures GFEs across its partner network

MDside's PC-MSO platform embeds the GFE requirement into every clinical workflow from day one. Our physician-owned professional corporations maintain clinical protocols that define GFE requirements by treatment category, document all examinations in a compliant medical record system, and ensure that supervising practitioners are licensed in the states where patients are being seen.

For partners operating multi-state telehealth programs — wellness clinics, med spas with multiple locations, and businesses like gyms adding hormone therapy programs — our provider network includes licensed clinicians in all active states, so the GFE requirement is met without requiring your business to build a clinical hiring infrastructure.

Our security and trust infrastructure also addresses the documentation side: patient records are maintained in systems that meet applicable healthcare privacy standards, with audit logs and access controls appropriate for sensitive medical information.

What happens when the GFE is missing or inadequate

State medical boards are the primary enforcement mechanism for GFE violations. Board complaints against aesthetic practitioners frequently cite inadequate pre-treatment evaluation as a contributing factor — particularly in cases involving adverse events (vascular occlusion from filler, nerve injury, allergic reaction). When the medical record shows no pre-treatment evaluation or a clearly inadequate one, the practitioner's defense is severely weakened.

At the facility level, consequences can include:

• Revocation or suspension of the medical director's license, which effectively shuts the clinical program
• State health department investigations into the facility's operating practices
• Civil liability to patients harmed by treatments that a proper examination would have flagged as contraindicated
• In cases involving controlled substances, DEA enforcement against the prescribing practitioner

These are not theoretical risks. Regulatory actions against med spas and aesthetic practices have increased significantly in the past several years, and inadequate clinical oversight — including missing or pro-forma GFEs — is one of the most cited deficiencies.

The good-faith exam is ultimately not a compliance burden — it is the foundation of safe, defensible clinical practice. Talk to MDside about how to embed it properly in your patient workflow, whether you're launching a new aesthetic program or auditing an existing one.